1. Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: A multi-center prospective observational study, the PARM-T2D study. (October 2022) Authors: Kito, Kenichi; Nomoto, Hiroshi; Sakuma, Ichiro; Nakamura, Akinobu; Cho, Kyu Yong; Kameda, Hiraku; Miya, Aika; Omori, Kazuno; Yanagiya, Shingo; Handa, Takahisa; Taneda, Shinji; Takeuchi, Jun; Nagai, So; Yamashita, Kumiko; Kurihara, Yoshio; Atsumi, Tatsuya; Miyoshi, Hideaki Journal: Diabetes research and clinical practice Issue: Volume 192(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study. Issue 8 (5th February 2021) Authors: Cho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Omori, Kazuno; Tsuchida, Kazuhisa; Miya, Aika; Shigesawa, Ikumi; Tsuchida, Kenichi; Yanagiya, Shingo; Kameda, Hiraku; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; ... Journal: Journal of diabetes investigation Issue: Volume 12:Issue 8(2021) Page Start: 1417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗